Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 13 | 2022 | 283 | 3.640 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2023 | 79 | 3.140 |
Why?
|
| Intestinal Mucosa | 9 | 2020 | 187 | 2.090 |
Why?
|
| Colon | 8 | 2023 | 138 | 1.750 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 70 | 1.690 |
Why?
|
| Sleep | 5 | 2018 | 272 | 1.560 |
Why?
|
| Intestinal Absorption | 3 | 2015 | 36 | 1.350 |
Why?
|
| Cell Membrane Permeability | 3 | 2015 | 57 | 1.350 |
Why?
|
| Melatonin | 5 | 2016 | 96 | 1.220 |
Why?
|
| Work Schedule Tolerance | 2 | 2020 | 38 | 1.200 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 39 | 1.090 |
Why?
|
| Endotoxemia | 3 | 2015 | 26 | 1.020 |
Why?
|
| Circadian Clocks | 3 | 2022 | 35 | 1.020 |
Why?
|
| Colitis | 2 | 2023 | 37 | 0.880 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 11 | 0.850 |
Why?
|
| Mercaptopurine | 1 | 2023 | 3 | 0.850 |
Why?
|
| Ethanol | 7 | 2022 | 129 | 0.830 |
Why?
|
| Colitis, Ulcerative | 4 | 2022 | 60 | 0.760 |
Why?
|
| Feeding Behavior | 2 | 2019 | 76 | 0.750 |
Why?
|
| Gastrointestinal Tract | 2 | 2011 | 50 | 0.700 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 35 | 0.700 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 16 | 0.630 |
Why?
|
| Period Circadian Proteins | 3 | 2021 | 25 | 0.610 |
Why?
|
| Sleep Hygiene | 1 | 2017 | 2 | 0.600 |
Why?
|
| Chronobiology Disorders | 1 | 2017 | 14 | 0.590 |
Why?
|
| Mice | 8 | 2023 | 1198 | 0.530 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 22 | 0.530 |
Why?
|
| Intestine, Small | 1 | 2016 | 27 | 0.530 |
Why?
|
| Humans | 27 | 2023 | 25234 | 0.520 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2016 | 39 | 0.520 |
Why?
|
| Animals | 11 | 2023 | 3382 | 0.510 |
Why?
|
| Male | 20 | 2022 | 13575 | 0.490 |
Why?
|
| Permeability | 5 | 2021 | 127 | 0.470 |
Why?
|
| Crohn Disease | 2 | 2011 | 39 | 0.470 |
Why?
|
| Radiation Injuries | 1 | 2013 | 23 | 0.440 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 69 | 0.420 |
Why?
|
| Intestines | 4 | 2021 | 104 | 0.420 |
Why?
|
| Adult | 12 | 2020 | 7091 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 359 | 0.410 |
Why?
|
| Wine | 1 | 2011 | 6 | 0.390 |
Why?
|
| CLOCK Proteins | 1 | 2011 | 27 | 0.370 |
Why?
|
| Sleep Wake Disorders | 1 | 2011 | 109 | 0.340 |
Why?
|
| Feces | 3 | 2023 | 109 | 0.340 |
Why?
|
| Alcoholism | 2 | 2022 | 66 | 0.330 |
Why?
|
| Middle Aged | 11 | 2020 | 8145 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2022 | 181 | 0.320 |
Why?
|
| Female | 13 | 2020 | 13876 | 0.310 |
Why?
|
| HIV Infections | 3 | 2018 | 432 | 0.280 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2016 | 10 | 0.250 |
Why?
|
| Time Factors | 3 | 2019 | 1329 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 512 | 0.240 |
Why?
|
| Young Adult | 6 | 2018 | 1751 | 0.240 |
Why?
|
| Photoperiod | 2 | 2021 | 47 | 0.230 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 11 | 0.220 |
Why?
|
| Thioguanine | 1 | 2023 | 3 | 0.220 |
Why?
|
| Azathioprine | 1 | 2023 | 7 | 0.210 |
Why?
|
| Chronotherapy | 1 | 2023 | 9 | 0.210 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 59 | 0.210 |
Why?
|
| Mindfulness | 1 | 2022 | 33 | 0.200 |
Why?
|
| Osteogenesis | 1 | 2022 | 96 | 0.200 |
Why?
|
| Choline | 1 | 2022 | 5 | 0.200 |
Why?
|
| Pilot Projects | 1 | 2023 | 361 | 0.190 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.190 |
Why?
|
| Luciferases | 1 | 2021 | 21 | 0.190 |
Why?
|
| Risk Factors | 3 | 2022 | 2175 | 0.190 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 1038 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 167 | 0.180 |
Why?
|
| Prospective Studies | 2 | 2023 | 1596 | 0.180 |
Why?
|
| Colonic Polyps | 1 | 2019 | 14 | 0.170 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 20 | 0.170 |
Why?
|
| Obesity | 1 | 2022 | 266 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2018 | 11 | 0.160 |
Why?
|
| Case-Control Studies | 1 | 2020 | 541 | 0.160 |
Why?
|
| Motor Activity | 1 | 2021 | 305 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 125 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2018 | 29 | 0.150 |
Why?
|
| Bisacodyl | 1 | 2018 | 2 | 0.150 |
Why?
|
| Cathartics | 1 | 2018 | 4 | 0.150 |
Why?
|
| Isotonic Solutions | 1 | 2018 | 10 | 0.150 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 6 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 33 | 0.150 |
Why?
|
| Organoids | 1 | 2017 | 8 | 0.150 |
Why?
|
| Biomarkers | 3 | 2016 | 554 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 40 | 0.150 |
Why?
|
| Stem Cells | 1 | 2017 | 37 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2018 | 117 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 53 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 836 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 14 | 0.130 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 3 | 0.120 |
Why?
|
| Inflammation | 1 | 2017 | 255 | 0.120 |
Why?
|
| Hepatitis B | 1 | 2014 | 12 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 24 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 72 | 0.120 |
Why?
|
| Vaccination | 1 | 2014 | 29 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 83 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 233 | 0.120 |
Why?
|
| Disease Progression | 2 | 2022 | 652 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2014 | 49 | 0.110 |
Why?
|
| Liver | 1 | 2014 | 122 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 100 | 0.110 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2012 | 4 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2012 | 4 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2018 | 3105 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 34 | 0.100 |
Why?
|
| Portal Vein | 1 | 2012 | 38 | 0.100 |
Why?
|
| Lactulose | 1 | 2011 | 8 | 0.100 |
Why?
|
| Sucrose | 1 | 2011 | 17 | 0.100 |
Why?
|
| Mannitol | 1 | 2011 | 12 | 0.100 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 7 | 0.100 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 50 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2022 | 76 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 95 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 727 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 904 | 0.090 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 7 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 305 | 0.090 |
Why?
|
| Saliva | 1 | 2010 | 49 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4523 | 0.080 |
Why?
|
| Rats | 1 | 2011 | 599 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 26 | 0.080 |
Why?
|
| Aged | 3 | 2018 | 8433 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2010 | 597 | 0.070 |
Why?
|
| Biopsy | 2 | 2018 | 191 | 0.070 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 10 | 0.050 |
Why?
|
| Methylamines | 1 | 2022 | 3 | 0.050 |
Why?
|
| Lyases | 1 | 2022 | 8 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2022 | 233 | 0.050 |
Why?
|
| Leptin | 1 | 2022 | 19 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 121 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2022 | 210 | 0.040 |
Why?
|
| Butyrates | 1 | 2019 | 23 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 21 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 184 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 52 | 0.040 |
Why?
|
| Electrolytes | 1 | 2018 | 13 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 596 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Keratin-20 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Jejunum | 1 | 2017 | 12 | 0.040 |
Why?
|
| Chromogranin A | 1 | 2017 | 10 | 0.040 |
Why?
|
| Occludin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2017 | 24 | 0.040 |
Why?
|
| Cadherins | 1 | 2017 | 35 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2017 | 22 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 103 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2017 | 39 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 151 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 162 | 0.040 |
Why?
|
| Ileum | 1 | 2015 | 17 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2015 | 63 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 264 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 6 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 22 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 95 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 61 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 100 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 74 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 41 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 106 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 118 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 438 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 421 | 0.030 |
Why?
|
| Microbiota | 1 | 2014 | 95 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 24 | 0.030 |
Why?
|
| Adolescent | 1 | 2018 | 1998 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 792 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 332 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 686 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 816 | 0.020 |
Why?
|